
The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
According to a story from BioSpace, Janssen Pharmaceutical Companies recently announced that the European Commission (EC) has expanded the approved indication of the company's drug ustekinumab (marketed as Stelara). This…